Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation. Neither IGC,
the medical associations, nor the authors endorse any product or service associated with the
distributor of this clinical reference tool.
Source
Wells SA, Asa, SL, Dralle H et al. e American yroid Association Guidelines for
the Management of Medullary yroid Carcinoma. e American yroid Association
Guidelines Task Force on Medullary yroid Carcinoma. yroid, a Mary Ann Liebert,
Inc. publication. yroid. 2015. [Epub ahead of print]
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2015 All rights reserved
ATATHY15053a
Abbreviations
ADX, adrenalectomy; ATA, American yroid Association; CEA, carcinoembryonic
antigen; CLA, cutaneous lichen amyloidosis; Ctn, Calcitonin; EBRT, external beam
radiotherapy; FNA, fine needle aspiration; HD, Hirschsprung's Disease; HPTH,
hyperparathyroidism; IHC, immunohistochemical; LND, lymph node dissection;
M, metastatic MTC; MTC, medullary thyroid carcinoma; N, node; PHEO,
pheochromocytoma; RET, REarranged during Transfection; TFTs, thyroid function
tests; TKI, tyrosine kinase inhibitor; TSH, thyroid stimulating hormone; TTX, total
thyroidectomy; US, ultrasound; VEGF, vascular endothelial growth factor receptor
American yroid Association, Inc.
6066 Leesburg Pike, Suite 550 • Falls Church, Virginia 22041
Phone: 703.998.8890 • Fax: 703.998.8893 • www.thyroid.org
Physician referral, patient resources available online in English and Spanish.
